<DOC>
	<DOCNO>NCT00180427</DOCNO>
	<brief_summary>`` The purpose study evaluate influence rate response function implantable cardioverter defibrillator ( ICDs ) frequency ventricular arrhythmia patient ICD . ''</brief_summary>
	<brief_title>VERRARI - `` Are Ventricular Arrhythmic Episodes Reduced Rate Response ICDs ? ''</brief_title>
	<detailed_description>`` Background : Studies show bradycardia irregular heart rate may increase incidence ventricular arrhythmia . Regularizing heart rate avoid bradycardias rate responsive pacing may way reduce arrhythmia . This prospective , open-label , randomized multicenter study . Inclusion criterion : Patients indication ICD accord AHA/ACC-guidelines get rate response system 5 % rate adaptive pace one month screen phase may include give write informed consent . Rate adaptive pacing must contraindicate , patient must able perform 6 min walk test , must NYHA IV life expectancy 18 month . Patients randomly assign 6 month rate responsive pacing follow 6 month rate responsive pacing , vice versa respectively . At 6 12 month follow ups , ICD store data , arrhythmic episode , medication , anamnesis , quality life , 6 min walktest , echocardiographic parameter optionally spiroergomatry evaluate compare . ''</detailed_description>
	<mesh_term>Ventricular Fibrillation</mesh_term>
	<criteria>indication ICD accord ACC/AHA guideline ICD rate response function implant least 5 % rate response ventricular pace one month screen phase sign informed patient consent '' rate responsive pacing contraindicate patient able perform 6 min walktest heart failure NYHA IV life expectancy 18 month ''</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>